March 14, 2023 – I worked on Capitol Hill and in state houses across the country for years, before a seemingly benign OxyContin prescription for pain sent me into a decade-long tailspin that nearly ended my life. If I had not been able to access medication for opioid use disorder (MOUD) treatment with buprenorphine, I would not be here today. Since the beginning of my recovery in 2015, I’ve made it my purpose to increase access to treatment for every single American who needs it—without shame, judgement or unnecessary barriers.
On Feb. 24, the Drug Enforcement Administration (DEA) announced new federal telemedicine guidelines that will roll back access to buprenorphine over telehealth and will contribute to more opioid overdoses and deaths. The DEA has proposed a rule that would limit telemedicine prescriptions for buprenorphine to a single 30-day supply. Under the DEA’s guidelines, any new opioid use disorder patient who starts their treatment via telemedicine must find and see an in-person provider in order to renew their prescription beyond the initial 30 days.
GIVING BACK IN STYLE – April 17, 2024 - “It’s still one day at…
RIDING THE WAVE...CALMLY – April 18, 2024 - “I was 13 years old and…
VIDEO – NEW YORK STORIES – April 23, 2024 - Sara Gettelfinger had steadily…
TRY IT, YOU’LL LIKE IT – April 18, 2024 - The rise in “sober…
AUDIO – SOBER MEN CAN DO THAT – April 4, 2024 - Acting icon…
I’LL BET HE GOES TO GA (not Georgia) – April 13, 2024 -The initial…